Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol
- Resource Type
- article
- Source
- BMJ Open, Vol 12, Iss 2 (2022)
- Subject
Medicine - Language
- English
- ISSN
- 2044-6055